Financhill
Back

Abbott Laboratories Quote, Financials, Valuation and Earnings

Abbott Laboratories Price Quote

$114.14
-0.74 (-0.64%)
(Updated: September 19, 2024 at 6:55 PM ET)

Abbott Laboratories Key Stats

Buy
57
Abbott Laboratories (ABT) is a Buy

Day range:
$114.52 - $117.50
52-week range:
$89.67 - $121.64
Dividend yield:
1.88%
P/E ratio:
35.24
P/S ratio:
4.93
P/B ratio:
5.08%

Volume:
5.9M
Avg. volume:
4.6M
1-year change:
13.74%
Market cap:
$199.9B
Revenue:
$40.1B
EPS:
$3.17

How Much Does Abbott Laboratories Make?

Is Abbott Laboratories Growing As A Company?

  • What Is Abbott Laboratories's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.04%
  • What Is Abbott Laboratories's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.05%

Abbott Laboratories Stock Price Performance

What Is Abbott Laboratories 52-Week High & Low?

Abbott Laboratories Price To Free Cash Flow

Is It Risky To Buy Abbott Laboratories?

Is Abbott Laboratories Cash Flow Positive?

  • What Is ABT Cash Flow From Operations?
    Cash flow from operations (TTM) is $7.9B
  • What Is Abbott Laboratories’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$6.4B
  • What Is Abbott Laboratories’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$2.3B

Abbott Laboratories Return On Invested Capital

  • Is Management Doing A Good Job?
    ABT return on invested capital is 10.33%
  • What Is Abbott Laboratories Return On Assets?
    ROA measures how assets are converting to revenues and is 7.63%
  • What Is ABT Return On Equity?
    ROE is a measure of profitability and is 14.43%

Abbott Laboratories Earnings Date & Stock Price

Abbott Laboratories Competitors

  • Who Are Abbott Laboratories's Competitors?
    Below is a list of companies who compete with Abbott Laboratories or are related in some way:
    • Becton Dickinson & Co (BDX)
    • Boston Scientific Corp (BSX)
    • Globus Medical Inc (GMED)
    • Integra Lifesciences Holdings Corp (IART)
    • Intuitive Surgical Inc (ISRG)

Abbott Laboratories Dividend Yield

Abbott Laboratories Analyst Estimates

YoY Growth Past Surprise
EPS: -5.13% 3.17%
Revenue: 4% 0.08%

Analyst Recommendations

Buy Recommendations: 12
Hold Recommendations: 7
Sell Recommendations: 0
Price Target: 123.81
Upside from Last Price: 7.77%

Major Shareholders

  • How many ABT shares are owned by institutional investors?
    2.2B ABT shares are owned by institutional investors
  • How many ABT shares are owned by insiders?
    15.1M ABT shares are owned by insiders